Cargando…

Accuracy of a High Prostate-Specific Antigen Level for Prostate Cancer Diagnosis upon Initial Biopsy in Korean Men

PURPOSE: This study aimed to evaluate the cancer detection rate in a Korean population with prostate-specific antigen (PSA) levels greater than or equal to 20.0ng/mL. MATERIALS AND METHODS: A total of 174 men 50 to 79 years old (median 69) included in the study. The median prostate volume of the pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Hong Bang, Lee, Sang Eun, Park, Hyoung Keun, Ku, Ja Hyeon
Formato:	Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628051/ https://www.ncbi.nlm.nih.gov/pubmed/17722242 http://dx.doi.org/10.3349/ymj.2007.48.4.678

Ejemplares similares

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men
por: Byun, Hyun Keun, et al.
Publicado: (2012)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Initial Biopsy Outcome Prediction in Korean Patients-Comparison of a Noble Web-based Korean Prostate Cancer Risk Calculator versus Prostate-specific Antigen Testing
por: Park, Jae Young, et al.
Publicado: (2011)

Pre- and Post-Operative Nomograms to Predict Recurrence-Free Probability in Korean Men with Clinically Localized Prostate Cancer
por: Kang, Minyong, et al.
Publicado: (2014)

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy
por: Wang, Fu-Bo, et al.
Publicado: (2017)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Impacts of the Quinazoline-Based Alpha1-Antagonist, Terazosin, and of the Sulfonamide Derivative, Tamsulosin, on Serum Prostate-Specific Antigen and Prostate Volume
por: Paick, Jae-Seung, et al.
Publicado: (2008)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy
por: Simmons, Lucy A M, et al.
Publicado: (2017)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population
por: Suh, Jungyo, et al.
Publicado: (2020)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
por: Rosario, Derek J, et al.
Publicado: (2012)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy
por: Agnihotri, Shalini, et al.
Publicado: (2014)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy
por: Chang, Chao-Hsiang, et al.
Publicado: (2017)

An overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy
por: Patwardhan, Sujata K., et al.
Publicado: (2018)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
por: Hupe, Marie Christine, et al.
Publicado: (2018)

Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml
por: Kim, Hyoung Woo, et al.
Publicado: (2011)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
por: Koc, Gokhan, et al.
Publicado: (2017)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
por: Sakamoto, Yoshiro, et al.
Publicado: (2014)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Is Prostate Biopsy Essential to Diagnose Prostate Cancer in the Older Patient with Extremely High Prostate-Specific Antigen?
por: Jang, Jee Young, et al.
Publicado: (2012)

Value and Safety of Midazolam Anesthesia during Transrectal Ultrasound-Guided Prostate Biopsy
por: Song, Jin Hyun, et al.
Publicado: (2011)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
por: Teoh, Jeremy YC, et al.
Publicado: (2015)

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study
por: Boesen, Lars, et al.
Publicado: (2018)

Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy
por: Bang, Jun-Ho, et al.
Publicado: (2013)

COMPARISON OF GRADING ACCURACY OF PROSTATE CANCER IN SAMPLES ACQUIRED BY A TARGETED AND SYSTEMIC PROSTATE BIOPSY
por: Pezelj, Ivan, et al.
Publicado: (2022)

Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria
por: Nnabugwu, Ikenna I, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g4cg9deq6kepf180noj553u522